![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
. | ![]() |
. |
![]() by Brooks Hays Washington DC (UPI) Dec 31, 2020
The Asian tiger mosquito poses only a minor risk for Zika virus, according to new epidemiological simulations. The yellow fever mosquito Aedes aegypti is the primary vector for Zika virus, the infectious disease that can spread from mother to fetus, causing congenital deformities. However, lab experiments have previously shown the Asian tiger mosquito Aedes albopictus can carry and transmit the disease. In 2019, scientists in France blamed several instances of Zika infection and transmission on the Asian tiger mosquito, an aggressive biter that originates from Southeast Asia but has colonized much of temperate Europe. Thanks to its ability to survive harsh winters, the Asian tiger mosquito is now found all over the world. The species is the second-most common vector of viral pathogens in humans, but until now, its ability to trigger major Zika virus outbreaks hadn't been investigated. For the study, published Thursday in the journal PLOS Pathogens, researchers exposed Asian tiger mosquitoes to the Zika virus and assessed the insect's ability to carry and transmit the virus in variety of lab experiments. Scientists also modeled the dynamics of Zika virus infection in humans, and designed new epidemiological simulations to gauge the ability of the species to trigger large-scale Zika outbreaks. The combination of experiments and models showed the greatest risk of Zika transmission occurred during the symptomatic stage of the disease. During the symptomatic stage, scientists estimated the odds of a mosquito picking up the disease at 20 percent. "Despite these unfavorable characteristics for transmission, Ae. albopictus was still able to trigger and yield large outbreaks in a simulated environment in the presence of sufficiently high mosquito biting rates," researchers wrote in their paper. "Our results reveal a low but existing epidemic potential of Ae. albopictus for Zika." Even with a low risk of causing Zika outbreaks in Europe, researchers suggest active surveillance and eradication programs should be deployed to safeguard public health in places with significant Asian tiger mosquito populations.
![]() ![]() Turkey to start using China's Covid-19 vaccine after strong results Istanbul (AFP) Dec 24, 2020 Turkey will receive its first shipment of China's Sinovac coronavirus vaccine within days as preliminary domestic tests showed it was 91% effective, Health Minister Fahrettin Koca said on Thursday. Ankara in the next few days will also sign a deal with Pfizer/BioNTech for 4.5 million doses, with the option to buy 30 million more from the US pharmaceutical giant and its German partner, Koca said Turkey will initially receive three million doses of Sinovac and have the option for 50 million more a ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |